Disproportionate Inhibition of Feeding in Ay Mice by Certain Stressors: A Cautionary Note

A study of the effects of insulin-induced hypoglycemia in the obese yellow agouti Ay mouse was initiated to test the hypothesis that the central melanocortin pathways are required for a normal sympathetic response to hypoglycemia. An experimental protocol was performed in which young nonobese male mice were isolated and fasted beginning on day 1, then tested for glucose responses to insulin-induced hypoglycemia on day 2. Normal mice demonstrated the expected glucose rebound to hypoglycemia, exceeding baseline glucose levels by 2–3 times as a consequence of increased gluconeogenesis and glycogenolysis before returning to baseline levels. Ay animals lacked the rebound, exhibiting instead a gradual restoration of baseline glucose levels. The results suggested a defective sympathetic response to hypoglycemia in the Ay mouse. However, a more detailed analysis demonstrated that the lack of a hyperglycemic rebound was due to an acute inhibition of feeding specifically in the Ay mouse, which resulted not from the hypoglycemia stressor, but rather from the stress of isolation. Handling and intraperitoneal administration of saline also specifically inhibited food intake in the Ay but not the wild-type mouse, while restraint stress had an equivalent inhibitory effect on food intake on wild-type and Ay mice. Since the Ay mouse has defective hypothalamic melanocortin-4 receptor (MC4-R) signaling, these data imply that the central melanocortin pathway is necessary for regulating the effects of stress on feeding behavior. Furthermore, these data demonstrate the need for exercising extreme caution in designing experiments to analyze feeding behavior and metabolism in genetic or pharmacological models involving perturbation of the melanocortin system.

[1]  L. Yaswen,et al.  Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin , 1999, Nature Medicine.

[2]  J. Hebebrand,et al.  Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. , 1999, The Journal of clinical endocrinology and metabolism.

[3]  R. Palmiter,et al.  Response of melanocortin–4 receptor–deficient mice to anorectic and orexigenic peptides , 1999, Nature Genetics.

[4]  A. Mark,et al.  Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. , 1999, Hypertension.

[5]  K. Clément,et al.  A frameshift mutation in human MC4R is associated with a dominant form of obesity , 1998, Nature Genetics.

[6]  S. O’Rahilly,et al.  A frameshift mutation in MC4R associated with dominantly inherited human obesity , 1998, Nature Genetics.

[7]  R. Adan,et al.  The role of central melanocortin receptors in the activation of the hypothalamus‐pituitary‐adrenal‐axis and the induction of excessive grooming , 1998, British journal of pharmacology.

[8]  R. Cone,et al.  Independent and additive effects of central POMC and leptin pathways on murine obesity. , 1997, Science.

[9]  J. Shutter,et al.  Overexpression of Agrt leads to obesity in transgenic mice , 1997, Nature Genetics.

[10]  G. Barsh,et al.  Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. , 1997, Science.

[11]  R. Cone,et al.  Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.

[12]  G. Barsh,et al.  Obesity, diabetes, and neoplasia in yellow Avy/‐ mice: ectopic expression of the agouti gene , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  G. Chrousos,et al.  Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion. Potential clinical implications. , 1988, The Journal of clinical investigation.

[14]  G. Wolff,et al.  Prenatal determination of obesity, tumor susceptibility, and coat color pattern in viable yellow (Avy/a) mice. The yellow mouse syndrome. , 1986, The Journal of heredity.

[15]  T. Suda,et al.  Inhibitory effect of adrenocorticotropin on corticotropin- releasing factor release from rat hypothalamus in vitro. , 1986, Endocrinology.

[16]  J. Jolles,et al.  Intracerebroventricular ACTH activates the pituitary-adrenal system:dissociation from a behavioral response. , 1979, Life sciences.

[17]  G. Wolff,et al.  Genetic regulation of plasma corticosterone concentration and its response to castration and allogeneic tumour growth in the mouse. , 1971, Nature: New biology.